These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 26070313)

  • 1. Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom.
    Philippou Y; Raja H; Gnanapragasam VJ
    BMC Urol; 2015 Jun; 15():52. PubMed ID: 26070313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.
    Iremashvili V; Manoharan M; Rosenberg DL; Soloway MS
    BJU Int; 2013 Apr; 111(4):574-9. PubMed ID: 22564446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Gross CP; Nguyen PL; Smaldone MC; Shah ND; Karnes RJ; Thompson RH; Han LC; Yu JB; Trinh QD; Ziegenfuss JY; Sun M; Tilburt JC
    Med Care; 2014 Jul; 52(7):579-85. PubMed ID: 24926704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Shah ND; Meropol NJ; Tilburt JC; Nguyen PL; Yu JB; Abouassaly R; Kim A; Gross CP
    Eur Urol Oncol; 2019 Mar; 2(2):189-195. PubMed ID: 31017095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Gross CP; Shah ND; Tilburt JC; Konety B; Williams SB; Weight CJ; Yu JB; Kumar AMS; Meropol NJ
    Ann Surg Oncol; 2019 Feb; 26(2):660-668. PubMed ID: 30311161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active Surveillance as Initial Management of Newly Diagnosed Prostate Cancer: Data from the PURC.
    Botejue M; Abbott D; Danella J; Fonshell C; Ginzburg S; Guzzo TJ; Lanchoney T; Marlowe B; Raman JD; Smaldone M; Tomaszewski JJ; Trabulsi EJ; Uzzo RG; Reese AC
    J Urol; 2019 May; 201(5):929-936. PubMed ID: 30720692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?
    Descazeaud A; Rubin MA; Allory Y; Burchardt M; Salomon L; Chopin D; Abbou C; de la Taille A
    Eur Urol; 2005 Dec; 48(6):911-5. PubMed ID: 16140457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial.
    Wade J; Holding PN; Bonnington S; Rooshenas L; Lane JA; Salter CE; Tilling K; Speakman MJ; Brewster SF; Evans S; Neal DE; Hamdy FC; Donovan JL;
    BMJ Open; 2015 Sep; 5(9):e008953. PubMed ID: 26384727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences and commonalities in the management of locally advanced prostate cancer: results from a survey of oncologists and urologists in the UK.
    Payne HA; Gillatt DA
    BJU Int; 2007 Mar; 99(3):545-53. PubMed ID: 17407513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.
    Ariane MM; Ploussard G; Rebillard X; Malavaud B; Rischmann P; Hennequin C; Mongiat-Artus P
    World J Urol; 2015 Nov; 33(11):1741-7. PubMed ID: 25822706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriateness Criteria for Active Surveillance of Prostate Cancer.
    Cher ML; Dhir A; Auffenberg GB; Linsell S; Gao Y; Rosenberg B; Jafri SM; Klotz L; Miller DC; Ghani KR; Bernstein SJ; Montie JE; Lane BR;
    J Urol; 2017 Jan; 197(1):67-74. PubMed ID: 27422298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Influencing Selection of Active Surveillance for Localized Prostate Cancer.
    Liu J; Womble PR; Merdan S; Miller DC; Montie JE; Denton BT;
    Urology; 2015 Nov; 86(5):901-5. PubMed ID: 26358397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy and surgery for high-risk localized prostate cancer: a UK questionnaire survey of urologists and clinical oncologists.
    Gnanapragasam VJ; Persad R; Payne HA
    BJU Int; 2012 Sep; 110(5):608-12. PubMed ID: 22765394
    [No Abstract]   [Full Text] [Related]  

  • 15. Current use of active surveillance for localized prostate cancer: A nationwide survey in Japan.
    Mitsuzuka K; Koga H; Sugimoto M; Arai Y; Ohyama C; Kakehi Y; Naito S
    Int J Urol; 2015 Aug; 22(8):754-9. PubMed ID: 25959857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists.
    Ellis SD; Hwang S; Morrow E; Kimminau KS; Goonan K; Petty L; Ellerbeck E; Thrasher JB
    BMC Cancer; 2021 May; 21(1):649. PubMed ID: 34058998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging Characteristics of Prostate Cancer Patients Who Discontinued Active Surveillance on 3-T Multiparametric Prostate MRI.
    Habibian DJ; Liu CC; Dao A; Kosinski KE; Katz AE
    AJR Am J Roentgenol; 2017 Mar; 208(3):564-569. PubMed ID: 28075651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.
    Womble PR; Montie JE; Ye Z; Linsell SM; Lane BR; Miller DC;
    Eur Urol; 2015 Jan; 67(1):44-50. PubMed ID: 25159890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active surveillance for low-risk prostate cancer: knowledge, acceptance and practice among urologists.
    Gorin MA; Eldefrawy A; Ekwenna O; Soloway MS
    Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):177-81. PubMed ID: 22143447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge, attitudes, and practices of active surveillance in prostate cancer among urologists: a real-life survey from Brazil.
    Wroclawski ML; Amaral BS; Kayano PP; Busato WFS; Westphal SJ; Montagna E; Bianco B; Soares A; Maluf FC; Lemos GC; Carneiro A
    BMC Urol; 2022 Jun; 22(1):86. PubMed ID: 35706024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.